Get started
Author

Akio Moriya

Roles of alcohol consumption in fatty liver: A longitudinal study
2014 · Akio Moriya, Yoshiaki Iwasaki, et al. · Journal of Hepatology · 113
Alcohol consumption appears to protect against non-alcoholic fatty liver disease
2010 · A. Moriya, Y. Iwasaki, et al. · Alimentary Pharmacology & Therapeutics · 110
Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study
2020 · Joji Tani, Asahiro Morishita, et al. · Oncology Letters · 56
PDF
Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
2011 · Haruhiko Kobashi, Yasuhiro Miyake, et al. · Hepatology Research · 45
The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study
2020 · the KTK49 Liver Study Group, Akito Nozaki, et al. · Hepatology International · 35
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
2022 · Asahiro Morishita, Kyoko Oura, et al. · Hepatology International · 34
PDF
Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
2019 · Hidenori Toyoda, Masanori Atsukawa, et al. · Journal of Gastroenterology and Hepatology · 32
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
2018 · Hidenori Toyoda, Masanori Atsukawa, et al. · Journal of Gastroenterology · 29
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
2017 · Chikara Ogawa, Masahiro Morita, et al. · Oncology · 28
Long‐term monitoring of platelet count, as a non‐invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy
2006 · Hideaki Taniguchi, Yoshiaki Iwasaki, et al. · Journal of Gastroenterology and Hepatology · 25
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
2024 · Tatsuya Kikuchi, Yasuto Takeuchi, et al. · Liver International · 24
PDF
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
2020 · Masanori Atsukawa, Akihito Tsubota, et al. · Infectious Diseases and Therapy · 23
PDF
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
2021 · Masanori Atsukawa, Akihito Tsubota, et al. · Hepatology Research · 20
Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan
2019 · Hiroki Ikeda, Tsunamasa Watanabe, et al. · Journal of Viral Hepatitis · 18
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy
2023 · Kyoko Oura, Asahiro Morishita, et al. · Cancers · 17
PDF
Extensive liver metastasis of gastric cancer effectively treated by hepatic arterial infusion of 5-fluorouracil/cisplatin
2000 · Akio Moriya, Ichinosuke Hyodo, et al. · Gastric Cancer · 17
PDF
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma
2022 · Tetsu Tomonari, Joji Tani, et al. · Hepatology Research · 13
Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma
2021 · Atsushi Oyama, Kazuhiro Nouso, et al. · Hepatology Research · 13
Sequential therapy including regorafenib for unresectable hepatocellular carcinoma: Effect of early relative changes in hepatic functional reserve after regorafenib administration on prognosis
2021 · Hironori Ochi, Joji Tani, et al. · Hepatology Research · 12
Overlap of IgG4-related Sclerosing Cholangitis and Primary Biliary Cirrhosis
2014 · Reika Takemoto, Yasuhiro Miyake, et al. · Internal Medicine · 12
PDF
Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
2020 · Hideaki Taniguchi, Yoshiaki Iwasaki, et al. · JGH Open · 11
PDF
The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
2019 · Kenji Kuwaki, Kazuhiro Nouso, et al. · PubMed · 11
PDF
Intrahepatic mRNA Levels of Type I Interferon Receptor and Interferon-Stimulated Genes in Genotype 1b Chronic Hepatitis C
2006 · Hideaki Taniguchi, Yoshiaki Iwasaki, et al. · Intervirology · 11
Hepatitis B Virus Gene in Liver Tissue Promotes Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients
2003 · Shin-Ichi Fujioka, Hiroyuki Shimomura, et al. · Digestive Diseases and Sciences · 11
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
2021 · Joji Tani, Tomonori Senoh, et al. · Cancers · 9
PDF
Works count: 70
Citation count: 811
H-index: 16
I10-index: 24
Year
Topic
Type